Marketmind: A sticky inflation situation

Fear of US-China Conflict Looms Over Singapore Defense Forum

Anthos Therapeutics' Novel Dual-Acting Factor XI/XIa Inhibitor, Abelacimab 150 mg, Demonstrated a 67% Reduction in the Primary Endpoint of Major or Clinically Relevant Non-Major Bleeding Compared with Rivaroxaban in Patients with Atrial Fibrillation

Generational's Ryan Binkley to Receive M&A Advisor Leadership Award and Induction into Hall of Fame

In the Market: Funds fret over the fallout of Biden's China order

Bank of Israel to sell $30 billion of forex to moderate shekel's volatility

Business groups sue US labor board to block contract, franchise worker rule

Diesel Cars Moved From London to the North After Ulez Expansion